Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network

PHASE3CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Heart Defects, CongenitalHeart Failure, Congestive
Interventions
DRUG

Enalapril

Enalapril to target dose of .4mg/kg/day divided to twice per day (BID)

DRUG

Placebo

Participants will receive placebo

Trial Locations (9)

10032

Columbia College of Physicians and Surgeons, New York

19104

Children's Hospital of Philadelphia, Philadelphia

27710

Duke University Medical Center, Durham

29425

Medical University of South Carolina, Charleston

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

53226

Children's Hospital of Wisconsin, Milwaukee

84113

Primary Children's Hospital, Salt Lake City

02115

Children's Hospital Boston, Boston

M5G 1X8

Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

Pediatric Heart Network

OTHER

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00113087 - Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network | Biotech Hunter | Biotech Hunter